Renishaw appoints new board positions

Renishaw has made changes to its board of directors, with the appointment of a Chief Financial Officer, Chair and Senior Independent Director.

John Shipsey (pictured) has been appointed as Chief Financial Officer and Executive Director, effective 13 April 2026. John joins with significant board and executive leadership experience, having undertaken the role of CFO in various companies, including Dyson, Smiths Group and Featurespace. He also held finance and strategy roles at Diageo earlier in his career and served as a non-executive director of Dechra Pharmaceuticals.

Sir David Grant, Chair, comments: “I would like to welcome John to Renishaw and its board. John brings a deep understanding of the industrials sector and its associated performance drivers. He has a strong track record of leading high-performing finance functions, and we look forward to him strengthening both the board and executive leadership team.”

Will Lee, CEO at Renishaw, adds: “John’s breadth of financial and executive leadership experience, combined with his deep understanding of the industrials sector, will be invaluable to us as we work towards our strategic targets.”

Renishaw has also announced that Sir David Grant has been appointed as its permanent Chair with immediate effect for a period of up to two years. Sir David had been acting as Interim Chair and the board considered that he had consistently demonstrated the competencies and leadership required of the Chair, and his permanent appointment is in the best interests of the company and shareholders at this time. The search process for the company’s next Chair will continue with the aim of making an appointment by 2028.

Juliette Stacey has also been appointed to the role of Senior Independent Director with immediate effect. Juliette was originally appointed as an Independent Non-executive Director of the Company on 1 January 2022 and has been Chair of the Audit Committee and served as a member of the Nomination and Remuneration Committees since her appointment.